← Leaderboards
Edward Paul Monaghan
Thesan Pharmaceuticals Inc
$1,131,780
Attributed
$1,131,780
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $983.5K · FY2012–19$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$1,131,780 · 2
By mechanism
R44$983,495 · 1
R43$148,285 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Member”
- David R. Weir · University Of Michigan At Ann Arbor$340,329,837
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Barton F Haynes · Duke University$312,190,812
- Jeffrey P Krischer · University Of South Florida$296,624,284
- Norman Wolmark · Nsabp Foundation, Inc.$262,548,790
Research focus
MemberSmall Business Innovation Research GrantInflammationMedicinePlaySignal TransductionCysteineEnzymesLipidsMedicalPalmidrolPharmaceutical PreparationsAmidaseSafetyAcidsCaliforniaAnalgesicsDrug KineticsInhibitor/AntagonistBiologicalAnimal ModelBiologyAnimalsTranslating